3.03
price down icon1.30%   -0.04
after-market Dopo l'orario di chiusura: 3.05 0.02 +0.66%
loading
Precedente Chiudi:
$3.07
Aprire:
$3.01
Volume 24 ore:
127.77K
Relative Volume:
0.74
Capitalizzazione di mercato:
$1.08B
Reddito:
$842.96M
Utile/perdita netta:
$-185.63M
Rapporto P/E:
-5.7616
EPS:
-0.5259
Flusso di cassa netto:
$-228.52M
1 W Prestazione:
-7.62%
1M Prestazione:
-17.66%
6M Prestazione:
-11.92%
1 anno Prestazione:
-16.76%
Intervallo 1D:
Value
$2.985
$3.05
Intervallo di 1 settimana:
Value
$2.97
$3.28
Portata 52W:
Value
$2.84
$4.80

Evotec Se Adr Stock (EVO) Company Profile

Name
Nome
Evotec Se Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
4,766
Name
Cinguettio
Name
Prossima data di guadagno
2025-04-17
Name
Ultimi documenti SEC
Name
EVO's Discussions on Twitter

Compare EVO vs TAK, ZTS, HLN, TEVA, UTHR

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
EVO
Evotec Se Adr
3.03 1.09B 842.96M -185.63M -228.52M -0.5259
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
18.07 56.49B 29.85B 776.90M 4.35B 0.2408
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
122.36 51.26B 9.47B 2.67B 2.28B 6.0218
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.26 45.79B 14.54B 2.22B 2.58B 0.4879
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
31.50 36.16B 17.41B 1.43B 1.00B 1.2182
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
529.17 20.96B 3.13B 1.27B 1.12B 26.39

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-02-03 Iniziato Berenberg Buy
2025-04-24 Aggiornamento Deutsche Bank Sell → Hold
2024-10-07 Downgrade Jefferies Buy → Hold
2024-08-08 Downgrade Deutsche Bank Hold → Sell
2024-07-29 Downgrade Morgan Stanley Overweight → Equal-Weight
2024-07-11 Downgrade Deutsche Bank Buy → Hold
2024-04-12 Aggiornamento Deutsche Bank Hold → Buy
2024-01-18 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2023-06-23 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2023-06-16 Downgrade BofA Securities Buy → Neutral
2023-06-08 Aggiornamento Citigroup Neutral → Buy
2023-04-04 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2022-12-09 Iniziato H.C. Wainwright Buy
2022-11-16 Downgrade Deutsche Bank Buy → Hold
2022-08-10 Downgrade Morgan Stanley Overweight → Underweight
2022-03-02 Ripresa Cowen Outperform
2022-01-07 Ripresa Citigroup Neutral
Mostra tutto

Evotec Se Adr Borsa (EVO) Ultime notizie

pulisher
Mar 06, 2026

Evotec Aktie | DE0005664809 | ETR:EVT | News & Aktienkurs | FRA:EVT - LYNX Online Broker

Mar 06, 2026
pulisher
Feb 03, 2026

Evotec shares surge 8% as Berenberg initiates with “buy” on partner value - Investing.com

Feb 03, 2026
pulisher
Jan 21, 2026

Antibody Optimization Service (Affinity Maturation, Humanization, Phage Display, AI-based Computational Optimization) Market Trends Analysis and Growth Forecast Report 2025-2033 - GlobeNewswire Inc.

Jan 21, 2026
pulisher
Jan 18, 2026

Is Evotec SE (EVO) One of the Best Debt-Free Penny Stocks to Buy Right Now? - Finviz

Jan 18, 2026
pulisher
Jan 13, 2026

Financial Review: Evotec (NASDAQ:EVO) & Savara (NASDAQ:SVRA) - Defense World

Jan 13, 2026
pulisher
Jan 07, 2026

JustEvotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access - Chartmill

Jan 07, 2026
pulisher
Jan 01, 2026

Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations - Chartmill

Jan 01, 2026
pulisher
Dec 11, 2025

Taxes of Evotec SE Sponsored ADR – LSX:A0QZ3J - TradingView — Track All Markets

Dec 11, 2025
pulisher
Dec 08, 2025

EvotecHow Low A Company May Go While Still Being Attractive (NASDAQ:EVO) - Seeking Alpha

Dec 08, 2025
pulisher
Nov 08, 2025

Evotec AG Earnings Call: Resilience Amidst Challenges - MSN

Nov 08, 2025
pulisher
Nov 08, 2025

Evotec AG Reports Strategic Shift Amid Mixed Performance - MSN

Nov 08, 2025
pulisher
Nov 07, 2025

Annual General Meeting - Evotec

Nov 07, 2025
pulisher
Nov 07, 2025

Investor Relations - Evotec

Nov 07, 2025
pulisher
Nov 05, 2025

Evotec shares tumble 9% as drug discovery segment weakens - Investing.com

Nov 05, 2025
pulisher
Nov 04, 2025

symbol__ Stock Quote Price and Forecast - CNN

Nov 04, 2025
pulisher
Oct 13, 2025

ETFs Investing in Evotec SE Sponsored ADR Stocks - TradingView

Oct 13, 2025
pulisher
Oct 07, 2025

Evotec (NASDAQ:EVO) versus CASI Pharmaceuticals (NASDAQ:CASI) Critical Survey - Defense World

Oct 07, 2025
pulisher
Sep 06, 2025

Evotec Ag’s Earnings Call: Mixed Sentiments and Strategic Moves - MSN

Sep 06, 2025
pulisher
Aug 28, 2025

Stock Information - Evotec

Aug 28, 2025
pulisher
Aug 15, 2025

Evotec SE ADR earnings missed by $0.07, revenue fell short of estimates - Investing.com Australia

Aug 15, 2025
pulisher
Aug 14, 2025

Evotec AG Reports Mixed H1 2025 Performance - TipRanks

Aug 14, 2025
pulisher
Aug 11, 2025

Ørsted announces plan for a rights issue with support from the Danish State as majority shareholder and gross proceeds of DKK 60 billion11.08.25NewsARIVA.DE - rova

Aug 11, 2025
pulisher
Aug 02, 2025

Evotec shares drop sharply after lowering 2025 revenue forecast - MSN

Aug 02, 2025
pulisher
Jul 30, 2025

Evotec and Sandoz plan potential sale of Toulouse biologics site - Investing.com

Jul 30, 2025
pulisher
Jul 21, 2025

Evotec stock tumbles after slashing 2025 revenue guidance - Investing.com

Jul 21, 2025
pulisher
Jun 12, 2025

EVT Stock Price and Chart — XETR:EVT - TradingView

Jun 12, 2025
pulisher
May 07, 2025

Evotec SE ADR earnings missed by $0.03, revenue fell short of estimates - Investing.com

May 07, 2025
pulisher
Apr 18, 2025

Evotec SE ADR earnings beat by $0.08, revenue topped estimates - Investing.com UK

Apr 18, 2025
pulisher
Apr 08, 2025

The integrin repertoire drives YAP-dependent epithelial:stromal interactions during injury of the kidney glomerulus - Nature

Apr 08, 2025
pulisher
Feb 26, 2025

Evotec SE Sponsored ADR Trade Ideas — LSX:A0QZ3J - TradingView — Track All Markets

Feb 26, 2025
pulisher
Dec 29, 2024

Evotec Stock: Some Recovery Has Come, Much More Is Expected (NASDAQ:EVO) - Seeking Alpha

Dec 29, 2024
pulisher
Nov 29, 2024

Evotec SE (NASDAQ: EVO) Announces Departure of Chief Operating Officer Dr. Craig Johnstone - Kalkine Media

Nov 29, 2024
pulisher
Nov 25, 2024

Markets Brief: Are Bank Stocks Expensive? - Morningstar

Nov 25, 2024
pulisher
Nov 15, 2024

ProShares Nanotechnology ETF Holdings - Quiver Quantitative

Nov 15, 2024
pulisher
Nov 15, 2024

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid By Investing.com - Investing.com South Africa

Nov 15, 2024
pulisher
Aug 13, 2024

Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar Canada

Aug 13, 2024
pulisher
Apr 25, 2024

Earnings call: Evotec SE meets 2023 guidance, appoints new CEO - Investing.com

Apr 25, 2024
pulisher
Oct 05, 2023

Sandoz Group AG-ADR (SDZNY) Stock Price, News & Analyst Forecast - eToro

Oct 05, 2023
pulisher
Feb 10, 2022

Evotec SEADR Shares Near 52-Week LowMarket Mover - Nasdaq

Feb 10, 2022
pulisher
Jan 29, 2022

Evotec SE Sponsored ADR Trade Ideas — NASDAQ:EVO - TradingView

Jan 29, 2022
pulisher
Oct 17, 2017

EVO Stock Price | Evotec SE ADR Stock Quote (U.S.: Nasdaq) - MarketWatch

Oct 17, 2017
pulisher
Mar 07, 2017

GLPG Stock Price | Galapagos N.V. ADR Stock Quote (U.S.: Nasdaq) - MarketWatch

Mar 07, 2017
pulisher
Jan 12, 2016

EVOEvotec SE ADR Stock Price and Quote - Finviz

Jan 12, 2016

Evotec Se Adr Azioni (EVO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.94
price up icon 2.48%
drug_manufacturers_specialty_generic RDY
$14.39
price down icon 0.07%
drug_manufacturers_specialty_generic RGC
$25.90
price up icon 10.92%
$129.93
price up icon 1.40%
$14.22
price up icon 0.42%
$529.17
price up icon 10.67%
Capitalizzazione:     |  Volume (24 ore):